Bartter syndrome: Benefits and side effects of long-term treatment

Pediatric Nephrology

Volumn 19, Issue 8, 2004, Pages 858-863

  Vaisbich, Maria Helena ^a,b   Fujimura, Maria Danisi ^a   Koch, Vera H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Gastric ulcer; Indomethacin; Potassium; Rofecoxib

Indexed keywords

ALDOSTERONE; BICARBONATE; CAPTOPRIL; INDOMETACIN; POTASSIUM; POTASSIUM CHLORIDE; RANITIDINE; RENIN; ROFECOXIB; SPIRONOLACTONE;

ADOLESCENT; ADULT; ARTICLE; BARTTER SYNDROME; BICARBONATE BLOOD LEVEL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DRUG DOSE REGIMEN; ELECTROLYTE DISTURBANCE; FAILURE TO THRIVE; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; GROWTH RATE; HUMAN; HYPOKALEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; KIDNEY CALCIFICATION; KIDNEY CYST; KIDNEY DISEASE; KIDNEY FUNCTION; LONG TERM CARE; MALE; METABOLIC DISORDER; PATIENT COMPLIANCE; POLYDIPSIA; POLYURIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SIDE EFFECT; STOMACH PAIN; STOMACH ULCER; VOMITING; WEIGHT REDUCTION;

EID: 4344562972     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1527-8     Document Type: Article

References (24)

1. Rodriguez-Soriano J (1998) Bartter and related syndromes. The puzzle is almost solved. Pediatr Nephrol 12:315-327
2. Guay-Woodford LM (1998) Bartter syndrome: unraveling the pathophysiologic enigma. Am J Med 105:151-161
3. Zelikovic I (2003) Hypokalemic salt-losing tubulopathies: an evolving story. Nephrol Dial Transplant 18:1696-1700
4. Peters M, Jeck N, Reinalter S, Leonhardt A, Tönshoff B, Klaus G, Konrad M, Seyberth H (2002) Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112:183-190
5. Littlewood JM, Lee MR, Meadow SR (1978) Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors. Arch Dis Child 53:43-48
6. Shalev H, Ohali M, Kachko L, Landau D (2003) The neonatal variant of Bartter syndrome and deafness: preservation of renal function. Pediatrics 112:628-633
7. Haas NA, Nossal R, Schneider CH, Lewin MAG, Ocker V, Holder M, Uhlemann F (2003) Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter's syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib. Pediatr Crit Care Med 4:249-251
8. Schurman S, Perlman AS, Sertphen R, Campos A, Garin E, Cruz D, Schoemaker L (2001) Genotype/phenotype observations in African Americans with Bartter syndrome. J Pediatr 139:105-110
9. Hene RJ, Koomans HÁ, Dorhout Mees EJ, Stople A, Verhoef GEG, Boer P (1987) Correction of hypokalemia in Bartter's syndrome by enalapril. Am J Kidney Dis 9:200-205
10. St Rose E, Ferrandiz M, Kiss M, Forre O, Vehe R, Higgins G, Rennenbohm R, Porras A, Wong P, DeTora LM, Truitt KE (2001) Steady-state plasma concentrations of rofecoxib in children (ages 2-5 years) with juvenile rheumatoid arthritis (JRA). Arthritis Rheum 44:S291
11. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nüsing RM, Seyberth HW, Kömhoff M (2002) Role of cyclooxigenase-2 in hyperprostaglandin E syndrome/antenatal Bartter symdrome. Kidney Int 62:253-260
12. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine and urea concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 34:571-590
13. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad AS, Lifton RP (1996) Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl, cotransporter NKCC2. Nat Genet 13:183-188
14. Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad AS, Lifton RP (1996) Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14:152-156
15. Simon DB, Bindra RS, Mansfield TA, Nelson-Willians C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad AS, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP (1997) Mutations in the chloride channel ClC-Kb cause Bartter's syndrome type III. Nat Genet 17:171-178
16. Simon DB, Nelson-Willians C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP (1996) Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12:24-30
17. Jeck N, Reinalter SC, Henne T, Marg W, Mallman R, Pasel K, Vollner M, Klaus G, Leonhardt A, Seyberth H, Konrad M (2001) Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 108:1-9
18. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Déchaux M, Miller RT, Antignac C (2002) Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 13:2259-2266
19. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360:692-694
20. Rudin A (1988) Bartter's syndrome. A review of 28 patients followed for 10 years. Acta Med Scand 224:165-171
21. Dillon MJ, Shah V, Mitchell MD (1979) Bartter's syndrome: ten cases in childhood. Q J Med 48:429-446
22. Sato K, Ogata M (1995) A patient with chronic renal failure due to Bartter's syndrome. Nippon Jinzo Shi 37:404-409
23. Rodriguez LAG, Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343:769-772
24. Barbosa PR, Abe JM, Oliveira LAN, Vaisbich MH, Koch VHK, Cerri GG (2003) Gastrocolic fistulae in Bartter's syndrome caused by indomethacin: report of two cases. Radiol Bras 36:179-181